CDKL5 Antibodies

Santa Cruz Biotechnology delivers a wide array of CDKL5 monoclonal antibodies for research in understanding CDKL5's role in various biological processes. CDKL5 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CDKL5, or cyclin-dependent kinase-like 5, is a serine/threonine kinase that plays a crucial role in neuronal development and function. Mutations in the CDKL5 gene are associated with severe neurodevelopmental disorders, including CDKL5 deficiency disorder, which is characterized by early-onset seizures and developmental delays. Understanding CDKL5 function is essential for elucidating its involvement in synaptic regulation and potential therapeutic targets for related disorders. CDKL5 monoclonal antibodies enable precise detection and analysis of CDKL5 expression patterns in neural tissues. Researchers can investigate CDKL5's molecular interactions and signaling pathways using multiple experimental approaches. Advanced imaging techniques combined with CDKL5 monoclonal antibodies allow visualization of protein localization in cellular compartments. Santa Cruz Biotechnology monoclonal antibodies for CDKL5 support researchers worldwide in advancing our understanding of neurological development and potential therapeutic interventions.